Interestingly, upregulated METTL3 was reported to promote β-catenin and c‐Myc expression, and mainly affect the biological progression of hepatoblastoma through the Wnt/β‐catenin pathway [42]. The gene discussed is MYC; the disease is hepatoblastoma.